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Edited by Veli-Pekka LehtoAbstract Hepatopoietin (HPO)/augmenter of liver regenera-
tion (ALR) is a speciﬁc hepatotrophic growth factor, which plays
a key role in liver regeneration. Our previous study indicated
that HPO executes its function by an inter-reactive network of
the autocrine, paracrine and endocrine pathways. Recently, we
have demonstrated that intracellular HPO interacts with Jun
activation domain-binding protein 1 (JAB1) and leads to
potentiation of activating protein-1 (AP-1) activity in a MAPK
independent fashion. JAB1 is the ﬁfth subunit of the COP9
signalosome (CSN), which is ﬁrst identiﬁed as a suppressor of
plant morphogenesis. A protein complex kinase activity associ-
ated with the CSN has been reported but not identiﬁed yet. In
this report, we investigated further the association of HPO with
the whole CSN. HPO exists in a complex with the eight-
component CSN, both when puriﬁed from glycerol gradient
centrifugation and when reciprocal immunoprecipitated from the
lysates of transfected COS-7 cells. Intracellular HPO colocal-
izes with endogenous CSN in nucleus of hepatic cells. In
addition, intracellular function of HPO that increases the
phosphorylation of c-Jun leading to potentiate the AP-1 activity
is inhibited by curcumin, a potent inhibitor of CSN-associated
kinase. Taken together, these results elucidate a novel relation-
ship of intracellular growth factor, HPO with large protein
complex, CSN, which suggests a possible linkage between CSN
and liver regeneration.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Hepatopoietin (HPO)/augmenter of liver regeneration
(ALR) is a novel polypeptide mitogen that originated from
liver and speciﬁcally augments hepatocytes proliferation [1].* Corresponding author. Fax: +8610-68171208.
E-mail address: hefc@nic.bmi.ac.cn (F. He).
Abbreviations: PBS, phosphate-buﬀered saline; HPO, hepatopoietin;
JAB1, Jun activation domain-binding protein 1; MAPK, mitogen-
activated protein kinase; AP-1, activating protein-1; JNK, c-Jun N-
terminal kinase; PAGE, polyacrylamide gel electrophoresis; COP9
signalosome (CSN), constitutive photomorphogenesis 9
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doi:10.1016/j.febslet.2004.07.012Yang et al. [2] ﬁrstly cloned the cDNA of HPO (rhHPO) from
human fetal liver lysates encoding 125 amino acids and 15 kDa
in molecular weight. Recombinant human HPO could stimu-
late proliferation of cultured hepatocytes as well as hepatoma
cells in vitro, promote regeneration and recovery of damaged
hepatocytes, and rescue acute hepatic failure in vivo [3,4]. HPO
exerts its hepatrophic activities through paracrine and auto-
crine pathways. Wang et al. characterized the mitogenic eﬀect
of paracritic HPO on hepatoma cell lines and demonstrated
the existence of HPO speciﬁc receptor on the surface of these
cells, and elucidated that HPO stimulates proliferation of he-
patocytes and enhances liver regeneration by activating the
mitogen-activated protein kinase cascade (MAPK signaling
pathway) under the mediation of HPO receptor, leading to
DNA synthesis of hepatic cells [5,6]. The existence of HPO in
the nucleus and cytosol of liver tissues further implicates that
HPO could have intracellular function in hepatocytes. We used
the full-length HPO as bait in the yeast two-hybrid system to
screen a human fetal liver cDNA library. Among the speciﬁ-
cally interacting clones was Jun activation domain-binding
protein 1 (JAB1), co-activator of c-Jun/activating protein-1
(AP-1) transcription factor, which enhances binding of c-Jun-
containing AP-1 complex to their DNA consensus site and
increases transactivation of an AP-1-dependent promoter [7].
Lu et al. [8] further demonstrated the association of HPO and
JAB1 in vitro or in vivo and suggested the biological eﬀect of
interaction of HPO with JAB1 on the speciﬁc modulation of
AP-1-mediated transcription in a MAPK-independent fashion.
JAB1 is also known as a subunit (CSN5, S5) of mammalian
COP9 signalosome (CSN) that is highly conserved from yeast
to human [9]. The CSN was ﬁrst identiﬁed in Arabidopsis
thaliana as an eight-subunit complex involved in the suppres-
sion of light-dependent development [10], and it has now been
found to participate in diverse cellular and developmental
processes in various eukaryotic organisms. Two known activ-
ities associated with the CSN are deneddylation and phos-
phorylation [11,12]. The associated deneddylase regulates the
activity of speciﬁc Skpl-Cullin-F-box protein complex E3
ubiquitin ligases [13]. The CSN-associated kinase phosphory-
lates transcription regulators such as p105, IjBa, c-Jun [9], and
p53 [14], which determine their stability towards the ubiquitin-
26S proteasome system. In contrast to c-Jun N-terminal kinase
(JNK), CSN-speciﬁc phosphorylation only modiﬁes full-length
of c-Jun and leads to its stabilization in HeLa cells, resulting ination of European Biochemical Societies.
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the CSN subunits contain a recognizable kinase domain and
the CSN kinase has not yet been identiﬁed, some protein ki-
nases have been found to associate with CSN kinase activity.
Recently, Sun et al. [16] proposed that inositol-1,3,4-tris-
phosphate-5/6-kinase (5/6-kinase) is the previously described
CSN-associated kinase in that they could be co-puriﬁed from
bovine brain, and both phosphorylated the same substrates.
Uhle et al. also proved that kinase activity of CSN are most
likely due to protein kinase CK2 and protein kinase D, which
are recruited by CSN in order to regulate Ub-proteasome-
dependent degradation [17]. Herein, we demonstrate that
intracrine HPO associated with CSN and regulated AP-1 ac-
tivity, which suggests a novel mechanism of intracrine cytokine
that exerts its signaling modulation function through protein
complex.2. Materials and methods
2.1. Chemicals, antibody and plasmid constructions
Chemicals were purchased from Sigma–Aldrich unless stated
otherwise. Reagents for SDS–polyacrylamide gel electrophoresis
(PAGE) were obtained from Bio-Rad. Tissue culture reagents were
purchased from Invitrogen Life Technologies Inc. HepG2 is the human
hepatoma cell line from ATCC.
Myc-tagged proteins were detected using mouse monoclonal anti-
body against a Myc-peptide (Cell signal technology). Anti-CSN5
(rabbit polyclonal antibody), anti-c-Jun (rabbit polyclonal antibody),
anti-p-c-Jun (mouse monoclonal antibody), anti-actin (goat polyclonal
antibody), peroxidase-conjugated goat-anti-mouse IgG, rabbit-anti-
goat IgG, goat-anti-rabbit IgG and ECL luminescence kit were all
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-
HPO mouse monoclonal antibody was a gift from Dr. Qing-ming
Wang. Anti-CSN1 (S1), -CSN2 (S2) and -CSN8 (S8) rabbit polyclonal
antibodies were kindly provided by Professor Ning Wei and Xing-
wang Deng (Department of Molecular, Cellular, and Developmental
Biology, Yale University, New Haven, USA).
For the immunoprecipitation and glycerol gradient centrifugation,
the full-length cDNA of HPO was subcloned into pCMV-Myc
(Clontech) expression vector in-frame with a Myc fusion protein. For
the Luciferase transactivation assay, full-length cDNA of HPO and
JAB1 were all subcloned into pcDNA3 (Invitrogen Life Technologies).
2.2. Protein assay and Western blotting
Cells were rinsed three times with ice-cold phosphate-buﬀered saline
(PBS) and lysed in the lysis buﬀers stated in each experimental step.
Cell debris was removed by centrifugation at 1000 g for 10 min at 4
C and the supernatants were collected for further treatments. Protein
concentration was determined as described by Bradford [18] with bo-
vine albumin serum (Roch) to make a standard curve. The protein
samples were fractionated via 10–15% SDS–polyacrylamide gel elec-
trophoresis and transformed to the PVDF membranes (Amersham
Pharmacia Biotech). The membranes were ﬁrst blocked by incubation
in TBS-T containing 5% non-fatty milk overnight at 4 C, then incu-
bated sequentially with primary antibody and HRP-conjugated sec-
ondary antibody, and detected using an ECL luminescence kit. Finally,
the acquired bands in the membranes were scanned by GS-710 Cali-
brated Imaging Densitometer (Bio-Rad) and precisely quantiﬁed using
PDQUEST 6.0 software package (Bio-Rad).
2.3. Cell culture, treatment and transient transfection
COS-7 cells and HepG2 cells were maintained as monolayer cultures
in Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% fetal
bovine serum, 2 mM L-glutamine, 100 g/ml streptomycin and 100 U/ml
penicillin at 37 C in a humidiﬁed 5% CO2 atmosphere. For transient
transfection, cells were seeded in tissue culture plates for 18–24 h prior
to infection. When the cell conﬂuence reached 90–95%, transfections
were performed using Lipofectamine 2000 reagent (Invitrogen Life
Technologies) as recommended by the manufacturer. In some experi-
ments, cells were treated with curcumin which was obtained fromSigma–Aldrich Chemical Co. Stock solutions of curcumin (20 mM)
were prepared in 100% DMSO and cells were treated with 50 lM
curcumin in combination for 3 h.2.4. Immunoprecipitation
COS-7 cells were transfected with pCMV-Myc-HPO coding for
Myc-HPO fusion or pCMV-Myc vector using lipofectamine reagent
(Invitrogen Life Technologies) according to the manufacturer’s in-
structions. After 48 h incubation, the cells were rinsed three times with
ice-cold PBS and lyzed in the lysis buﬀer (PBS containing 10 mM
CHAPS, 5 lg/ml chymostatin, 5 lg/ml leupeptin, 5 lg/ml pepstatin A,
1 mM Na3VO4 and 1 mM NaF). For immunoprecipitation, the cell
lysates were incubated with anti-Myc and anti-CSN1, CSN2, CSN5
(JAB1) and CSN8 antibodies, respectively, rotated at 4 C for 3 h.
Protein A/G–Sepharose beads (Santa Cruz Biotech) were added to the
reaction for another 3 h of incubation. The Sepharose beads were then
washed three times with lysis buﬀer and resuspended in 1 SDS–
PAGE loading buﬀer for immunoblotting analysis.
2.5. Immunoﬂuorescent staining
For physiological colocalization study of endogenous CSN and
HPO in vivo, HepG2 cells grown on 35 mm glass bottom microwell
cell culture dishes (MatTek corporation) were rinsed three times in
PBS and ﬁxed in 4% paraformaldehyde for 15 min, followed by per-
meabilization in 0.2% Triton X-100 for 15 min. Washed three times
with PBS, the samples were incubated with the blocking solution (3%
BSA and 5% newborn calf serum in PBS) for 1 h. The primary anti-
body diluted in blocking solution was incubated with the samples for 2
h. Unbound antibodies were washed with PBS containing 0.1% Tween
20 (PBS-T) for 3 5 min, and then were stained with ﬂuorescein iso-
thiocyanate (FITC)-linked anti-mouse and Rhodamine Red-linked
anti-rabbit IgG (Santa Cruz Biotechnology). After being washed with
PBS-T for 3 5 min, the samples were double stained with 1 lg/ml
40,6-diamidino-a-phenylinodole (DAPI). All cell samples were viewed
through a confocal laser-scanning microscope (Bio-Rad Radiance
2100), using the program of Laser Sharp 2000.2.6. Luciferase assays
COS-7 cells were plated on 24 wells plates at a density of 1 105/well
and were co-transfected with AP-1 driven luciferase reporter gene
(Stratagene), together with the indicated cDNAs, using the Lipofec-
tamine 2000 reagent. The AP-1 driven luciferase reporter gene is a
reporter plasmid encoding for the ﬁreﬂy luciferase gene driven by
several copies of an AP-1 enhancer. The indicated cDNAs were
pcDNA3-c-Jun coding for c-Jun, pcDNA3-JAB1 coding for JAB1 and
pcDNA3-HPO coding for HPO, respectively. Total DNA was kept
constant by the addition of the appropriate amount of pcDNA3 for all
transfections. At 16 h after transfection, cells were either treated for 3 h
with the indicated concentrations of 50 lM curcumin or left untreated
(DMSO as the control). Luciferase assays were performed at 3 h after
treatment with the Dual Luciferase Assay System (Promega) as rec-
ommended by the manufacturer. We normalized luciferase activity for
transfection eﬃciency by using a co-transfected internal control, pRL-
TK vector. The results were recorded on an Ultra-weak Luminescence
Analyzer. Representative results from more than three independent
experiments performed in triplicate are shown as fold induction or
compared with the control. Activities varied <10% between transfec-
tion experiments. The results were presented as meansS.D.
2.7. Glycerol gradient centrifugation
For separation experiment, 1.5 107 COS-7 cells transfected with
pCMV-Myc-HPO or pCMV-Myc vector or HepG2 cells were lysed in
lysis buﬀer containing 20 mM HEPES, pH 7.6, 140 mM NaCl, 1 mM
DTT, 10% glycerol, 0.1% Nonidet P-40 and CompleteTM protease
inhibitor tablets (Roche Molecular Biochemicals) and subjected to
density gradient centrifugation as described [9,15]. Brieﬂy, total cell
lysates went through three freeze–thaw cycles in liquid N2 and were
centrifuged at 4 C, 1000 g for 10 min to remove debrits. The su-
pernatants were ﬁltered through a 0.45 lm ﬁlter (Millipore) before
being separated on 10–40% density glycerol gradient centrifugation.
For glycerol gradient centrifugation analysis, 1 ml of cell lysate was
layered onto 10 ml of a 10–40% linear glycerol gradient containing 10
mM Tris–HCl, pH 8.0, 120 mM NaCl, 1 mM EDTA, and 1 mM b-
mercaptoethanol. After centrifugation for 24 h at 27 000 rpm in a
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proteins from fractions 1 to 16 were precipitated by trichloroacetic
acid, separated by SDS–PAGE, and analyzed by standard Western
blot using antibodies against Myc and CSN subunits.3. Results
3.1. HPO interacts with endogenous COP9 signalosome
We have demonstrated that HPO interacted with JAB1, the
ﬁfth subunit of CSN, both in vivo and in vitro [8]. To further
verify the speciﬁc association between HPO and the whole
CSN, we performed immunoprecipitation experiments to ob-
tain the speciﬁc complex formation in vivo between HPO and
CSN protein complex. Myc-tagged HPO was expressed in
COS-7 cells and anti-Myc or anti-CSN subunits antibodies
speciﬁcally precipitated complexes of Myc-HPO and endoge-
nous CSN. Speciﬁc precipitation of HPO was detected by anti-
Myc Western blot when anti-CSN subunits antibodies (CSN1,
CSN2, CSN5 and CSN8) but not control antibody was used
for immunoprecipitation, and precipitated CSN was shown by
anti-CSN1, -CSN2, -CSN5 and -CSN8 antibodies (Fig. 1A).
Moreover, anti-Myc monoclonal antibody could also pullFig. 1. The reciprocal immunoprecipitation suggested the assembly of
HPO–CSN complex. (A) COS-7 cells were transfected with Myc-tag-
ged HPO. At 48 h after transfection, the cells were lysed and cell lysates
were incubated with anti-Myc antibody or anti-S1, -S2, -S8, as well as
anti-JAB1 antibodies. The immuno-complex was conjugated by pro-
tein A/G–Agarose beads and then the immunoprecipitates were re-
solved on SDS–PAGE. The aliquots were analyzed by immunoblotting
with anti-Myc antibody. Lane 1 is a control for the other lanes with
rabbit mock antibody (normal IgG). Lane 5 is a positive control, since
HPO can form homodimer. A duplicate blot was also probed with
anti-Myc antibody to monitor the HPO protein inputted in each pre-
cipitation reaction (bottom). (B) CSN was immunoprecipitated either
by anti-HPO mouse monoclonal antibodies (Lane 5) or anti-S1, -S2,
-S5 and -S8 antibodies (Lanes 1, 2, 3 and 4). And the precipitated CSN
was detected by immuno-blotting with the related antibodies of the
subunits. Precipitation with mouse mock antibody (normal IgG)
served as negative controls (Lane C). Four lines of blots were also
probed with anti-Myc antibody to monitor HPO precipitated in each
reaction (right panel).down CSN complex as well as HPO (Fig. 1B), since HPO can
form homodimer in vivo [19]. The physiological interaction of
HPO with CSN by their reciprocal coimmunoprecipitation
implicated that the intracellular function of HPO could be
associated with CSN.
3.2. Physiological colocalization of HPO with COP9
signalosome within cells
The association between HPO and CSN was conﬁrmed
further in colocalization experiments (Fig. 2). The endogenous
HPO and CSN in human hepatoma line HepG2 cells were
visualized by double immuno-ﬂuorescence staining. HPO was
stained with green color and was observed mainly in nucleus
and very small portion in cytoplasm. Similarly, the endoge-
nous CSN was detected by its three subunits (CSN1, CSN2
and CSN8), respectively, that stained with red color. The
identical localization of these subunits was obtained that the
CSN existed primarily in nucleus (Fig. 2A–C) [14]. The merged
ﬁgure of each individual detection obviously demonstrated
that endogenous HPO and endogenous CSN had a similar
pattern of distribution or colocalization in HepG2 cell. The
fact that HPO colocalized with CSN implicated their physio-
logical interaction and the nucleus is the exact subcellular
compartment for the function performing of HPO through
CSN.3.3. Co-puriﬁcation of HPO and CSN in vivo further conﬁrmed
the natural binding
Because endogenous CSN can co-immunoprecipitate ec-
topical HPO and vice versa, we attempted to conﬁrm the
natural binding of HPO and CSN by transfection of COS-7
cells with plasmid containing Myc-tagged HPO, and a glycerol
gradient was performed on COS-7 cell lysates. The subunits of
CSN were detected in the complex using the antibodies against
CSN1, CSN2, CSN5 and CSN8; and expressed HPO was also
identiﬁed in the complex by the anti-Myc as well as anti-HPO
antibody, since the molecular weight of HPO is only 15 kDa,
which is much smaller than that of CSN (Fig. 3A). Further
signiﬁcant co-puriﬁcation of HPO and CSN was obtained by
the same method in HepG2 cells, which contain endogenous
HPO expression (Fig. 3B). The data presented demonstrate
that HPO is in fact associated with CSN, as indicated by im-
munoprecipitation. Therefore, the native interaction actually
provided the structural bases for the functional association
between HPO and CSN.
3.4. Curcumin inhibited AP-1 activity increment caused by
transient expression of HPO
CSN has been identiﬁed that phosphorylates cellular regu-
lators, such as p105, IjBa, c-Jun [9], and p53 [13], designating
their stabilization towards the ubiquitin proteolysis system.
CSN-speciﬁc phosphorylation of c-Jun leads to stabilization of
the transcription factor in HeLa cells, resulting in increased
AP-1 transcriptional activity [15]. Curcumin (Diferuloylme-
thane) has been reported to be the most eﬀective inhibitor of
the CSN kinase activity [14,20]. As the component of CSN,
JAB1 could activate the AP-1-dependent promoter [18,21,22].
In our previous results, HPO could modulate this AP-1 activity
by binding to JAB1. To test whether this process, further
mediated by CSN, we used curcumin to perform inhibitory
relative luciferase activity assays, in order to detect the eﬀect
Fig. 2. HPO colocalizes physically with CSN in HepG2. HepG2 cells were stained for endogenous HPO (green) and the three subunits of CSN (red),
S1, S2 and S8 in each experiment of A, B and C, respectively, by indirect immunoﬂuorescence. Cells were double stained with DAPI (blue) to identify
the nuclei in the corresponding ﬁelds. Merged pictures indicated the nucleic colocalization of HPO and the COP9 complex. All cell samples were
visualized by confocal microscopy (Bio-Rad), and the white bar indicated in A and C was 50 lm, and 10 lm in B.
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COS-7 cells were co-transfected with an AP-1-driven luciferase
reporter gene in the presence of c-Jun, JAB1, and HPO, and at
16 h after transfection, cells were either treated for 3 h with 50
lM of curcumin or left untreated (DMSO as the control). The
dual reporter gene activity was measured at 3 h after treat-
ment. The results indicated that curcumin completely inhibited
the HPO potentiation of AP-1 reporter gene activity (Fig. 4A).
Furthermore, the activation of AP-1 activity by ectopical ex-
pression of HPO was also blocked by the indicated concen-
tration of curcumin (Fig. 4B). These results together
demonstrated the involvement of CSN in the intracellular
signaling transduction pathway of HPO.
3.5. Curcumin inhibited the potentiation role of HPO on c-Jun
We have demonstrated that HPO-activated AP-1 promoter
activity and increased phosphorylation of c-Jun in a JNK-
independent way [8]. To further determine whether CSN
mediated this reaction, we then detected the levels of c-Jun as
well as phosphorylated c-Jun in COS-7 cells transfected withHPO, JAB1 or both, and treated or left untreated with curc-
umin. The results indicated that ectopically expressed HPO
increased the phosphorylated c-Jun concentration, which
conformed to our former results and curcumin actually de-
creased the level of phosphorylated c-Jun (Fig. 5) that elevated
by HPO, in agreement with the data suggested in AP-1 re-
portor gene transactivation assay (Fig. 4A). Meanwhile, we
also observed that c-Jun level was also aﬀected by curcumin
treatment, which indicated a subsequent instability of this
protein (Fig. 5) towards the Ubiquitin-26S proteasome system.4. Discussion
CSN complex consists of eight subunits that are highly
conserved from plants to mammals [23]. This complex has a
role in cell-signaling processes, which is manifested by its as-
sociated novel kinase activity and by the involvement of its
subunits in regulating multiple signaling pathways, cell-cycle
progression and developmental control. JAB1, the ﬁfth
Fig. 3. Co-puriﬁcation of HPO and CSN by glycerol gradient centrifugation. (A) COS-7 cells were transfected with Myc tagged HPO or pCMV-Myc
vector (control) and lysed in lysis buﬀer at 48 h after transfection. The cell lysates were fractionated through 10–40% glycerol gradient by centri-
fugation for 24 h at 27 000 rpm and 4 C. Fractions of 1–16 were analyzed by immunoblotting using the antibodies shown to the left of the panels. (B)
HepG2 cells were fractionated and detected using the same methods as in (A).
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shown to interact with a variety of cytokines, growth factors or
nuclear receptors. We have identiﬁed that JAB1 speciﬁcally
interacted with intracellular HPO both in vivo and in vitro,
which induced the potentiation of AP-1 transactivation func-
tion [8]. In this report, our data further demonstrated that
HPO associated with the whole CSN using several criteria.
The fact that the majority of endogenous JAB1 is in the
CSN complex prompted us to investigate whether other
components of CSN participate in the regulation of HPO.
Intracrine HPO could co-purify with CSN through glycerol
density gradient centrifugation. Meanwhile, the reciprocal
coimmunoprecipitation could identify the physiological inter-
action of HPO with CSN. In addition, initial characterization
of the CSN complex indicated that it is a large molecular
weight and multi-functional protein complex predominantly in
the nucleus [24–26]. In our work, we found the colocalization
of HPO with CSN mainly in the nucleus, which suggested the
existence in the same subcellular distribution and provided the
exact compartment for the direct interaction taken place.
Four individual subunits of CSN had been implicated, re-
spectively, in the AP-1-mediated transcription activation, and
puriﬁed CSN was reported to exhibit serine/threonine protein
kinase activity towards c-Jun, IjBa, p105, and p53. None of
the CSN subunits contain a recognizable kinase domain,
however. c-Jun, the speciﬁc form of transcription factor AP-1,
has been implicated in several cellular processes including
normal cell growth, diﬀerentiation, proliferation and cell
transformation [27]. We reported previously that HPO in-
creased the phosphorylation of c-Jun via JAB1 in a JNK in-
dependent manner. If the phosphorylation step is mediated by
CSN kinase, the interference of its kinase activity will aﬀect theintracellular eﬀect of HPO. The data presented here clearly
demonstrated that the CSN is a key player in the functional
regulation of HPO. The AP-1 activation potentiated by HPO
is sensitive to curcumin. Curcumin is a dietary pigment, which
has been described as a suppressor of tumor initiation and
promotion [28]. Curcumin is also known as a strong inhibitor
of AP-1 activation [29] and in consequence, a potent inhibitor
of the CSN-associated kinase activity [20]. Although curcumin
is also reported to inhibit the JNK pathway, as shown before
under our conditions, the JNK pathway is inactive [30], and
the inhibitory eﬀects of curcumin on phosphorylated c-Jun
levels and AP-1 activity, which increased by HPO are most
likely due to the inhibition of the CSN kinase. In addition, the
transcription factor stability of c-Jun towards Ubiquitin-26S
proteasome system is also mediated by CSN-speciﬁc phos-
phorylation [9,15]. Through the inhibition of kinase activity,
curcumin aﬀected the phosphorylation of c-Jun executed by
HPO and the consequence was the ubiquitination and sub-
sequent degradation of c-Jun by the 26S proteasome.
Recently, CSN has become a focus of interest for many re-
searchers for its function at the interface between signal
transduction and ubiquitin-dependent proteolysis [31,32],
which is required for the proper progression of the cell cycle in
yeast and is essential for development in plants and Drosophila
[33,34]. The new relationship of intracellular growth factor,
HPO with CSN that we described here suggested a possible
linkage between CSN and liver regeneration. Liver growth is
regulated by an inter-reactive network of the various auto-
crine, paracrine and endocrine factors. The role of HPO as a
stimulator of hepatocyte proliferation in liver regeneration has
been systematically investigated for years. HPO is constitu-
tively expressed in hepatocytes in an inactive form and released
Fig. 4. Curcumin inhibited the potentiation of AP-1 activity by HPO
via CSN. (A) HPO enhanced JAB1-mediated activation of AP-1 re-
porter gene activity in COS-7 cells. This process could be abrogated by
curcumin, the potent inhibitor of CSN associated kinase activity, as
analyzed by the AP-1 luciferase reporter assay. COS-7 cells were co-
transfected with AP-1-driven-luciferase reporter, c-Jun, JAB1 and
HPO. (B) Similarly, the AP-1 activity induced by HPO through en-
dogenous CSN was completely inhibited by curcumin. COS-7 cells
were cotransfected with AP-1-driven-luciferase reporter, c-Jun, and
HPO without ectopical JAB1. At 16–19 h after transfections, the cells
were incubated with 50 lM curcumin for 3 h. Each luciferase activity
was normalized to a cotransfected pRL-TK vector. Shown are repre-
sentative examples of at least three independent experiments per-
formed in triplicate. Activities varied <10% between transfection
experiments. The error bar indicates S.D.
Fig. 5. Curcumin inhibited the potentiation role of HPO on c-Jun. The
levels of c-Jun as well as phosphorylated c-Jun in COS-7 cells trans-
fected with HPO, JAB1 or both as indicated, and treated or left un-
treated with curcumin, were detected by immunoblotting analysis
using the antibodies shown to the left of the panels. The line of actin
indicated the equal loading as an internal control. The relative levels of
c-Jun and p-c-Jun, as measured by densitometry, are indicated below
the corresponding panels.
90 Y. Wang et al. / FEBS Letters 572 (2004) 85–91from cells in an active form during liver regeneration [1]. As to
our knowledge, HPO is the ﬁrst intracrine growth factor
identiﬁed to trigger AP-1 pathway through intracellular in-
teraction with a multicomponent protein regulator complex.
Taken together, with the increasing evidence concerning the
role of CSN in signal transduction and developmental control,
this versatile multicomponent complex serves as an important
integrator of cellular events. It can be speculated that HPO as
an intracrine factor triggers AP-1 pathway by regulation of
CSN for immediate early response when its intracellular level
is increased after partial liver hepatectomy or liver injury and
the CSN complex could represent an intracellular signal plat-
form, where signals from the extracellular or intracellular en-
vironment are coordinated with transcriptional activation and
with the regulation of the related functions of cells [8]. It would
be of interest to further investigate the concrete interaction
pattern of HPO and CSN complex. This may shed light on the
mechanism of intracrine HPO signaling and how the regula-
tion of the CSN acts as the capacity for liver regeneration.
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